Powered by Clearbit
Nektar Therapeutics (NAS: NKTR)+ to Company Analysis List
Address: 455 Mission Bay Boulevard South,San Francisco, CA 94158 United States  |  Phone: 415 482-5300   |  Company Website: www.nektar.com

Incorporated: July 1990 , CA, United States

Reincorporated: July 1998 , DE, United States

IRS Number: 943134940

Auditor: Ernst & Young LLP

Legal Counsel: O’Melveny & Myers LLP

Transfer Agent: Computershare Shareowner Services LLC, Jersey City, NJ

Country:  United States

Industry: Biotechnology (ICB 20103010)

Industry: Pharmaceutical preparations (SIC 2834)

Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412)

Number of Employees: 216 (Year End Average Staff as of 12/31/2022)

Number of Shareholders: 148 (approx. record) (as of 02/21/2023)

Market Cap: 242,984,280

Revenue: 93,157,000

Net Income: -177,081,000

EPS Basic: -0.9    EPS Diluted: -0.9

Download  Printer Friendly My Mergent Tools
Company Analysis List (0/500)
No company added to the Company Analysis List
Executive List (0/500)
No executive added to the Executive List
Mergent Private Company List (0/500)
No company added to the Mergent Private Company List
Company Alerts (0)
No alerts added to Alerts
Executive Alerts (0)
No alerts added to Executive Alerts
Annual Reports
Note: Company Reports selections are in PDF format. In order to view PDF selections, you must have Adobe Acrobat Reader

YearFile SizeLanguage
2022-12-31 10K or Int'l Equivalent1237KEnglish
2022-09-30 Interim614KEnglish
2022-06-30 Interim884KEnglish
2022-03-31 Interim611KEnglish
2022-03-22 Annual Information Form473KEnglish
2022-01-11 Management Discussion & Analysis2803KEnglish
2021-12-31 10K or Int'l Equivalent1163KEnglish
2021-11-12 Management Discussion & Analysis2084KEnglish
2021-09-30 Interim686KEnglish
2021-09-16 Miscellaneous53KEnglish
2021-06-30 Interim803KEnglish
2021-03-31 Interim666KEnglish
2020-12-31 10K or Int'l Equivalent1933KEnglish
2020-09-30 Interim525KEnglish
2020-06-30 Interim6526KEnglish
2020-03-31 Interim521KEnglish
2019-12-31 10K or Int'l Equivalent11620KEnglish
2019-09-30 Interim553KEnglish
2019-06-30 Interim455KEnglish
2019-03-31 Interim470KEnglish
2018-12-31 10K or Int'l Equivalent650KEnglish
2018-09-30 Interim421KEnglish
2018-06-30 Interim1409KEnglish
2018-03-31 Interim1458KEnglish
2017-12-31 10K or Int'l Equivalent1390KEnglish
2016-12-31 10K or Int'l Equivalent844KEnglish
2015-12-31 10K or Int'l Equivalent7408KEnglish
2014-12-31 10K or Int'l Equivalent539KEnglish
2013-12-31 10K or Int'l Equivalent670KEnglish
2012-12-31 10K or Int'l Equivalent665KEnglish
2011-12-31 Annual/10K Report1685KEnglish
2010-12-31 10K or Int'l Equivalent338KEnglish
2009-12-31 10K or Int'l Equivalent343KEnglish
2008-12-31 10K or Int'l Equivalent328KEnglish
2007-12-31 10K or Int'l Equivalent367KEnglish
2006-12-31 10K or Int'l Equivalent593KEnglish
2006-12-31 Annual Report2273KEnglish
2005-12-31 10K or Int'l Equivalent670KEnglish
2005-12-31 Annual Report702KEnglish
2004-12-31 Annual Report2365KEnglish
2003-12-31 Annual Report1382KEnglish
2002-12-31 Annual Report2029KEnglish
2001-12-31 10K or Int'l Equivalent307KEnglish
2001-12-31 Annual Report (Sup.)324KEnglish
2000-12-31 Annual Report1343KEnglish
1999-12-31 Annual Report1211KEnglish
1998-12-31 Annual Report1081KEnglish
1997-12-31 Annual Report770KEnglish
1996-12-31 Annual Report1107KEnglish










© 2015 Morningstar. All Rights Reserved. The information contain herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results